Russell Lebovitz
Works at
Lead investigator
Sources: openalex.org
Grants and prizes
Alzheimer's Drug Discovery Foundation
Biomarkers, Evaluation of the Clinical Utility of α-Synuclein Seed Amplification Assay as an Aid in the Diagnosis of Dementia and Differentiation of Dementia Subtypes, ADDF-20965211, 2023–2024, 11 Sept 2023
Alzheimer's Drug Discovery Foundation
Diagnostics Accelerator, Development and Commercialization of a Protein Misfolding Cyclic Amplification (PMCA) Clinical Test for Detection of Aggregates of Misfolded α-Synuclein in Plasma and Plasma Exosomes, ADDF-21187421, 2020–2021, 15 Nov 2020
Sources: openalex.org